DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $59,712,000 | +191.9% | 1,600,000 | +100.0% | 0.39% | +49.8% |
| Q1 2021 | $20,456,000 | +16.1% | 800,000 | 0.0% | 0.26% | +37.0% |
| Q4 2020 | $17,624,000 | +22.5% | 800,000 | 0.0% | 0.19% | -10.0% |
| Q3 2020 | $14,392,000 | -29.2% | 800,000 | 0.0% | 0.21% | -36.2% |
| Q2 2020 | $20,320,000 | +2427.4% | 800,000 | +2092.0% | 0.33% | +1956.2% |
| Q4 2019 | $804,000 | +200.0% | 36,496 | -27.0% | 0.02% | -33.3% |
| Q1 2016 | $268,000 | -54.9% | 50,000 | 0.0% | 0.02% | -45.5% |
| Q4 2015 | $594,000 | -27.7% | 50,000 | -50.0% | 0.04% | +33.3% |
| Q3 2015 | $822,000 | +17.8% | 100,000 | +100.0% | 0.03% | -21.4% |
| Q2 2015 | $698,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,813,392 | $67,676,000 | 17.58% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $114,954,000 | 7.53% |
| RTW INVESTMENTS, LP | 7,521,859 | $280,716,000 | 4.24% |
| DAFNA Capital Management LLC | 510,756 | $19,061,000 | 3.99% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 229,892 | $8,580,000 | 3.83% |
| Parkman Healthcare Partners LLC | 304,686 | $11,371,000 | 2.49% |
| Evolutionary Tree Capital Management, LLC | 141,324 | $5,274,000 | 2.43% |
| Eagle Health Investments LP | 161,125 | $6,013,000 | 2.06% |
| Lombard Odier Asset Management (Switzerland) SA | 636,011 | $23,736,000 | 1.20% |
| Woodline Partners LP | 1,000,325 | $37,332,000 | 0.70% |